FDA leaders worry agency will lose out on talent in gene therapy, cancer fields

Monday, October 7, 2019

BioPharma Dive – Food and Drug Administration leaders are concerned the agency won't be able to recruit and retain sufficient numbers of experts in fields that have undergone rapid scientific advances, such as cell and gene therapy or oncology.